Organization
Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
3 abstracts
Abstract
Primary localized malignant PEComa treated with surgery: A report of a large series of patients treated in a referral institution.Org: Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy,
Abstract
Trabectedin failure-free survival (TFFS) after resuming trabectedin (T) in advanced myxoid liposarcoma (MLPS) patients.Org: Italian National Cancer Institute, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, Adult Mesenchymal Tumour & Rare Cancer Medical Oncology Unit, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Department of Surgery, Brigham and Women's Hospital, Boston, MA,
Abstract
Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).Org: IRCCS Foundation National Cancer Institute, Milan, Italy, Molinette Hospital, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Fondazione Policlinico Campus Bio-Medico, Orthopaedic Institute Rizzoli,